28 related articles for article (PubMed ID: 17825002)
1. Estimation in semiparametric transition measurement error models for longitudinal data.
Pan W; Zeng D; Lin X
Biometrics; 2009 Sep; 65(3):728-36. PubMed ID: 19173696
[TBL] [Abstract][Full Text] [Related]
2. Effects of variance-function misspecification in analysis of longitudinal data.
Wang YG; Lin X
Biometrics; 2005 Jun; 61(2):413-21. PubMed ID: 16011687
[TBL] [Abstract][Full Text] [Related]
3. Marginal analysis of correlated failure time data with informative cluster sizes.
Cong XJ; Yin G; Shen Y
Biometrics; 2007 Sep; 63(3):663-72. PubMed ID: 17825000
[TBL] [Abstract][Full Text] [Related]
4. Estimating survival and association in a semicompeting risks model.
Lakhal L; Rivest LP; Abdous B
Biometrics; 2008 Mar; 64(1):180-8. PubMed ID: 17645782
[TBL] [Abstract][Full Text] [Related]
5. A note on the use of unbiased estimating equations to estimate correlation in analysis of longitudinal trials.
Sun W; Shults J; Leonard M
Biom J; 2009 Feb; 51(1):5-18. PubMed ID: 19197953
[TBL] [Abstract][Full Text] [Related]
6. Analysis of failure time data with multilevel clustering, with application to the child vitamin a intervention trial in Nepal.
Shih JH; Lu SE
Biometrics; 2007 Sep; 63(3):673-80. PubMed ID: 17825001
[TBL] [Abstract][Full Text] [Related]
7. A modified pseudolikelihood approach for analysis of longitudinal data.
Wang YG; Zhao Y
Biometrics; 2007 Sep; 63(3):681-9. PubMed ID: 17825002
[TBL] [Abstract][Full Text] [Related]
8. Power analyses for longitudinal trials and other clustered designs.
Tu XM; Kowalski J; Zhang J; Lynch KG; Crits-Christoph P
Stat Med; 2004 Sep; 23(18):2799-815. PubMed ID: 15344187
[TBL] [Abstract][Full Text] [Related]
9. Three methods for constructing parallel gatekeeping procedures in clinical trials.
Dmitrienko A; Soulakova JN; Millen BA
J Biopharm Stat; 2011 Jul; 21(4):768-86. PubMed ID: 21516568
[TBL] [Abstract][Full Text] [Related]
10. Applying survival methodology to adverse experience occurrences in controlled clinical trials.
Bortey EB; Gould AL
J Biopharm Stat; 1991; 1(1):57-66. PubMed ID: 1844691
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment models for thromboprophylaxis of medical patients.
Samama MM; Combe S; Conard J; Horellou MH
Thromb Res; 2012 Feb; 129(2):127-32. PubMed ID: 22047755
[No Abstract] [Full Text] [Related]
12. Numerical methods to summarize data.
Indrayan A; Satyanarayana L
Indian Pediatr; 1999 Nov; 36(11):1127-34. PubMed ID: 10745334
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
